Formulation Development_Intas_GB

Intas’ state-of-the-art research and development centre is continually engaged in the development of APIs and processes which are plant friendly to support the commercial model of the target territory. Intas’ talented team of 200+ scientists work closely with the business teams to identify products in early stage and initiate early research work.

Intas’ continuous R & D initiatives have strengthened its product basket with the delivery of niche and complex products. Intas is also actively involved in the development and commercialization of biologics, in adherence to the European and the US Regulatory guidelines. The company is also focused on the discovery and development of New Chemical Entities (NCEs) targeting cancer and neurodegenerative diseases such as bipolar disorder.

Focus on difficult to manufacture complex products, development of Non-infringing routes of synthesis (ROS), innovative design processes, new polymorphs, in-house biosimilars have helped Intas in achieving a dominant position in Europe, US and other key markets.

Watch jobs in this category